Research Articles
8% Dividend Yields To Energize Your Portfolio
2021-02-23
The death of fossil fuels is greatly exaggerated. Here are two midstream master limited partnerships offering 8% dividend yields in today’s low interest rate environment. One, Enterprise Products Partners (EPD) is reliable. The other one, Energy Transfer LP (ET) not so much. Try FAST Graphs for FREE Today! Disclosure: Long EPD. Disclaimer: The opinions in […]
Is the PEG Ratio a Good Valuation Metric or Not?
2021-02-22
FAST Graphs Analyze Out Loud – is The PEG Ratio a Good Valuation Metric or Not? Utilizing Facebook (FB), Campbell Soup (CPB), LKQ Corp (LKQ), 3M (MMM) and Southern Co (SO) Disclosure: Long LKQ, MMM. Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a […]
How To Know When To Sell A Tech Stock?
2021-02-18
Introduction One of the most common complaints I hear from investors is that their advisors or brokers like to tell them when to buy, but never tell them when to sell. Whether those criticisms are fair or not, the sell decision is certainly the most vexing decision that investors face. Nevertheless, there are several clichés […]
Chinese Growth Stocks – Alibaba Group Holding Limited & Baidu, Inc.
2021-02-17
Every FAST Graphs tells a data story. Therefore, I consider it the first step, albeit an essential first step prior to a more comprehensive research and due diligence effort. Furthermore, I often get requests from subscribers to cover certain stocks. Unfortunately, I cannot cover all the stocks that are requested, but I do try to […]
Lithia Motors: A Stellar Performer But It Ain’t Over Yet Baby
2021-02-16
This is a subscriber request follow-up on a video I produced in October 2019 on Lithia Motors Inc. (LAD) Titled: “Hot Stock On Earnings Beat – Lithia Motors Inc $LAD.” The stock was very inexpensive at that time trading at a blended P/E ratio of only 11.83 on a company with a long-term growth rate […]
Bristol Myers Squibb (BMY): Unloved & Underappreciated
2021-02-10
Bristol-Myers Squibb is a leading pharmaceutical company with a strong pipeline. However, the stock is been stagnant in 2020 and therefore remains significantly undervalued here at the beginning of 2021. With this video I attempt to illustrate reasons why the market has been neglecting this blue-chip and then elaborate on whether it is justified or […]